Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease
This study is ongoing, but not recruiting participants.
Sponsor:
CureVac GmbH
Information provided by (Responsible Party):
CureVac GmbH
ClinicalTrials.gov Identifier:
NCT00831467
First received: January 27, 2009
Last updated: January 11, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2012 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
No publications provided by CureVac GmbH
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):